BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coloretti I, Berlot G, Busani S, De Rosa FG, Donati A, Forfori F, Grasselli G, Mirabella L, Tascini C, Viale P, Girardis M. Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus. J Clin Med 2021;10:3500. [PMID: 34441796 DOI: 10.3390/jcm10163500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Zhang Y, Lu L, Li X, Wu Y, Yang Y, Li T, Cao W. Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1116738] [Reference Citation Analysis]
2 Mallat J. Special Issue "Pulmonary and Critical Care Practice in the Pandemic of COVID-19". J Clin Med 2022;11:1336. [PMID: 35268427 DOI: 10.3390/jcm11051336] [Reference Citation Analysis]
3 Bohländer F, Weißmüller S, Riehl D, Gutscher M, Schüttrumpf J, Faust S. The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin. Biomedicines 2021;9:1828. [PMID: 34944644 DOI: 10.3390/biomedicines9121828] [Reference Citation Analysis]